Emerald Mutual Fund Advisers Trust Cytokinetics Inc Transaction History

Emerald Mutual Fund Advisers Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$63.75 - $108.06 $4.6 Million - $7.79 Million	72,080 New	72,080 $5.05 Million
Q1 2023 May 04, 2023	SELL	$33.36 - $45.71 $5.97 Million - $8.18 Million	-178,902 Reduced 48.22%	192,097 $6.76 Million
Q4 2022 Feb 03, 2023	BUY	$35.77 - $51.11 $2.83 Million - $4.04 Million	79,096 Added 27.1%	370,999 $17 Million
Q3 2022 Oct 25, 2022	BUY	$38.54 - $54.52 $6.37 Million - $9.01 Million	165,324 Added 130.61%	291,903 $14.1 Million
Q2 2022 Jul 29, 2022	BUY	$33.93 - $48.92 $4.29 Million - $6.19 Million	126,579 New	126,579 $4.97 Million

404

126M

3.24M

2.14M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.35B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.